Roivant Sciences Ltd. (ROIV) Tops Q3 EPS by 48c
Tweet
Share
E-mail
Get Alerts ROIV Hot Sheet
Join SI Premium – FREE
Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q3 EPS of $0.23, $0.48 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $9.02 million versus the consensus estimate of $8.14 million.
For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Rocket Lab joins U.S. Space Force's $981M NITE-STAR contract
- Lockheed Martin wins $153 million in defense contracts
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
